Clinical Trial Update: Oral Care With 3% Hydrogen Peroxide (Oroxid®) in ICU - Effects on the Lower Airway Microbial Colonisation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing whether oral care with 3% hydrogen peroxide (Oroxid) in ICU affects lower airway microbial colonization and ventilator-associat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Oroxid (hydrogen peroxide 3% oral care solution)

Snippet

Sponsor: Charles University, Czech Republic | Conditions: VAP - Ventilator Associated Pneumonia | Phase 4 | Status: RECRUITING